Category

Archives

MTP

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

200 views | Jun 19 2023

The 2023 statement on homozygous familial hypercholesterolaemia (HoFH) provides updated clinical guidance, emphasizing phenotypic features over genotype, prioritizing combination LDL-C-lowering therapy, and recommending the creation of national screening programs and education initiatives to address global inequities in HoFH care. [Read the Full Post]